Souêtre E J, Qing W, Hardens M
Benefit Research Group, Clinical Economics & Quality of Life, Asnières, France.
Fundam Clin Pharmacol. 1994;8(2):101-7. doi: 10.1111/j.1472-8206.1994.tb00786.x.
Due to the increased need for cost-containment policies, most decision makers are facing the issue of the efficiency of health care strategies. In this context, economic evaluation becomes a major instrument. However, the credibility of economic data depends on a number of methodological steps: selection of strategy of economic evaluation (cost/effectiveness, cost/benefit, generation of economic hypotheses, study design (cross-sectional, prospective, naturalistic), data collection (data-base, physicians), data analysis (costing, statistics). In this respect, the conduct of proper economic evaluation relies on a combination of expertise in clinical epidemiology as well as in health economics.
由于对成本控制政策的需求增加,大多数决策者面临着医疗保健策略效率的问题。在这种背景下,经济评估成为一项主要手段。然而,经济数据的可信度取决于一系列方法步骤:经济评估策略的选择(成本/效果、成本/效益)、经济假设的生成、研究设计(横断面研究、前瞻性研究、自然主义研究)、数据收集(数据库、医生)、数据分析(成本核算、统计学)。在这方面,进行恰当的经济评估依赖于临床流行病学和卫生经济学方面的专业知识的结合。